---
title: "Replimune prices $150M underwritten offering of common stock and pre-funded warrants"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295402602.md"
description: "Replimune priced an underwritten offering of common stock and pre-funded warrants to raise approximately $150 million in gross proceeds. The deal includes 9,701,490 shares and warrants for 2,736,340 shares at $12.06 per share. Net proceeds are estimated at $140.5 million after expenses. Delivery is expected around August 11, 2026, under Form S-3 shelf registration."
datetime: "2026-08-10T11:53:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295402602.md)
  - [en](https://longbridge.com/en/news/295402602.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295402602.md)
generator: "portal-rs"
---

# Replimune prices $150M underwritten offering of common stock and pre-funded warrants

**Replimune priced an underwritten offering expected to raise approximately $150.0 million in gross proceeds.**

**Key Highlights:**

-   Underwriting agreement for 9,701,490 shares and pre-funded warrants for 2,736,340 shares priced at $12.06/share (warrants $12.0599).
-   Net proceeds estimated at approximately $140.5 million after underwriting discounts, commissions and offering expenses.
-   Pre-funded warrants exercisable anytime; exercise restricted to avoid >9.99% ownership without 61 days' notice.
-   Delivery of securities expected on or about August 11, 2026, subject to customary closing conditions.
-   Offering made under Form S-3 shelf registration (Registration No. 333-287536); prospectus supplement to be filed with the SEC.

Original SEC Filing: Replimune Group, Inc. \[ REPL \] - 8-K - Aug. 10, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [REPL.US](https://longbridge.com/en/quote/REPL.US.md)

## Related News & Research

- [16:20 ETRobbins LLP Urges REPL Investors Who Lost Money Investing in Replimune to Contact the Firm for Information About Leading the Class Action](https://longbridge.com/en/news/296649920.md)
- [Quantinno Capital Management LP Increases Stock Position in Replimune Group, Inc. $REPL](https://longbridge.com/en/news/296198190.md)
- [Jupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering | JUNS Stock News](https://longbridge.com/en/news/296638594.md)
- [RenX Enterprises Announces $2.6 Million Sale Agreement for Norman Berry Property  | RENX Stock News](https://longbridge.com/en/news/296622710.md)
- [QNB Corp. Announces Launch of Common Stock Offering | QNBC Stock News](https://longbridge.com/en/news/296398686.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**